Abstract: PUB035
Trends in Mortality Associated with CKD and Diabetes in the United States, 1999-2024: A CDC WONDER Analysis
Session Information
Category: Cardiovascular-Kidney-Metabolic Health
- 602 Cardiovascular-Kidney-Metabolic Health: Clinical
Authors
- Vijayarao, Sree Sindhu, University of Miami Miller School of Medicine, Miami, Florida, United States
- Kuraku, Dileep Raja, Vinnic'kij nacional'nij medicnij universitet imeni Mikoli Pirogova, Vinnytsia, Vinnytsia Oblast, Ukraine
- Patel, Diya, Gujarat Medical Education and Research Society, Ahmedabad, GJ, India
- Maqbool, Farkhanda, Bakhtawar Amin Medical and Dental College, Multan, Punjab, Pakistan
- Keshapogu, Nagarjuna, Vinnic'kij nacional'nij medicnij universitet imeni Mikoli Pirogova, Vinnytsia, Vinnytsia Oblast, Ukraine
- Khan, Nabiha, Faisalabad Medical University, Faisalabad, Punjab, Pakistan
- Thiyagarajan, Ragav Vikraman, Malaysia Medical Council, Federal Territory of Kuala Lumpur, Malaysia
- Chiluveru, Sricharan, Alluri Sitaramaraju Academy of Medical Sciences, Eluru, AP, India
- Narla, Sai Jahnu Sree Reddy, Paris Regional Medical Center, Paris, Texas, United States
- Nallagonda, Tarun, Government Medical College Siddipet, Siddipet, Telangana, India
- Venkatesh, Karthik Kanna, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, PY, India
- Bandi, Laxmi Prasanna, Kakatiya Medical College, Warangal, Telangana, India
- Tekuru, Yogesh, Saint Louis University, St. Louis, Missouri, United States
- Younas, Kashf, Bakhtawar Amin Medical and Dental College, Multan, Punjab, Pakistan
- Kalluri, Hara Gopal, Alluri Sitaramaraju Academy of Medical Sciences, Eluru, AP, India
- Maqbool, Tehmeena, Bakhtawar Amin Medical and Dental College, Multan, Punjab, Pakistan
Background
Chronic Kidney Disease (CKD) is a frequent, severe complication in diabetic patients, often preceding cardiovascular and kidney failure. Population-level impact requires updated analysis to identify ongoing disparities and mortality trends in the U.S.
Methods
We conducted a retrospective CDC WONDER analysis (1999–2024) using ICD-10 codes N18 (CKD) followed by E10-E14 (DM). Age-adjusted mortality rates (AAMR) were stratified by sex, race, census region, and urbanization. Joinpoint regression calculated Annual Percent Change (APC) and Average Annual Percent Change (AAPC) with p<0.05.
Results
From 1999 to 2024, there were 101,607 CKD–DM–associated deaths. The AAMR rose from 1.51 to 5.40 between 1999 and 2012, declined sharply to 0.31 in 2014, resurged to 2.16 in 2021, then decreased to 0.54 in 2024, with an overall AAPC of -5.27% (95% CI -20.11 to 12.33; p=0.533). Mortality was consistently higher in males than in females. (0.41 vs. 0.27). Notable spikes occurred in 2011-2012 (male peak 6.95, female peak 4.66) and again in 2021 (male 1.32, female 0.86). The highest rates occurred in those aged ≥85 years (AAMR 110.25), followed by ages 75-84 (AAMR 45.50), with a marked rise in ages 65-74 during 2019-2022. The South (AAPC 2.07%) and West (AAPC 1.91%) had the greatest burden. Long-term increases persisted among White populations (AAPC 2.62%, p<0.001), while Black individuals showed a significant decline (AAPC -10.76%, p<0.001).
Conclusion
CKD with DM remains a major U.S. mortality contributor with a non-linear trajectory. Findings urge early renal protection and targeted interventions.